source
- Amgen launches autoinjector study for GLP-1 candidate MariTide as Phase 3 readouts loomAmgen has begun a study of an autoinjector formulation of its GLP-1 drug candidate MariTide, as the company prepares for pivotal Phase 3 data expected next year. The candidate is marketed as havin…
- Congress faces Dec. 11 deadline to fund government, shaping lame-duck session and health-care agendaDemocrats have taken control of both the House and Senate, but Republicans will remain in power until the new Congress convenes in January. Lawmakers must pass a funding bill by Dec. 11 to avoid a…